Correlation Between Neuropace and Merit Medical

Can any of the company-specific risk be diversified away by investing in both Neuropace and Merit Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Merit Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neuropace and Merit Medical Systems, you can compare the effects of market volatilities on Neuropace and Merit Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Merit Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Merit Medical.

Diversification Opportunities for Neuropace and Merit Medical

0.42

Correlation Coefficient

Neuropace  Merit Medical

Very weak diversification

The 3 months correlation between Neuropace and Merit is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Merit Medical Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merit Medical Systems and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Merit Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merit Medical Systems has no effect on the direction of Neuropace i.e., Neuropace and Merit Medical go up and down completely randomly.

Pair Corralation between Neuropace and Merit Medical

Given the investment horizon of 90 days Neuropace is expected to generate 2.54 times more return on investment than Merit Medical. However, Neuropace is 2.54 times more volatile than Merit Medical Systems. It trades about 0.02 of its potential returns per unit of risk. Merit Medical Systems is currently generating about -0.01 per unit of risk. If you would invest  1,193  in Neuropace on December 3, 2024 and sell it today you would earn a total of  0.00  from holding Neuropace or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Neuropace  vs.  Merit Medical Systems

Neuropace

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Neuropace is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Merit Medical Systems

Risk-Adjusted Performance

Very Weak

Over the last 90 days Merit Medical Systems has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Merit Medical is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Neuropace and Merit Medical

The main advantage of trading using opposite Neuropace and Merit Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Merit Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merit Medical will offset losses from the drop in Merit Medical's long position.

The idea behind Neuropace and Merit Medical Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.